RxDoctor Payments DataLook up a doctor →

Vincenzo Giannelli, MD

Dermatology · Washington, DCNPI 1205881182

Payments from drug & device makers

$18,449in general payments, 2019–2025

Across 774 payments — averaging $23.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Journey Medical Corporation$2K
  • Pfizer$2K
  • Incyte Corporation$1K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
  • Sun Pharmaceutical Industries Inc.$969
  • plus $10K from 29 others

What the payments were for

  • Speaking & faculty fees$1351%
  • Travel & lodging$140%
  • Food & beverage$18,28599%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,449 in reported general payments places this provider in the 75th percentile of 73 dermatology providers in District of Columbia.

See all dermatology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$256,477
Medicare patients
590
Services billed
3,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinonide132$5,846
Ketoconazole175$3,378
Clobetasol Propionate52$3,291
Imiquimod39$1,264
Metronidazole20$1,217
Triamcinolone Acetonide122$967
Tretinoin12$687
Minoxidil44$537
Doxycycline Hyclate26$348
Ciclopirox11$333
ValacyclovirValacyclovir Hcl11$290
Mupirocin21$251
Terbinafine Hcl11$36

Paid to pharmacies, not to this prescriber.

Other dermatology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →